Lancashire and South Cumbria
Formulary
Formulary
12 Ear, nose and oropharynx
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
12-03-02 Oropharyngeal Fungal infections
| Nystatin Nystan® |
|
First Choice
|
| Oral suspension 100,000 units/mL Will be labelled in doses of 1mL unless alternative specifically requested |
|
Links
LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway- LSCMMG: Primary Care Constipation Guidelines
- MHRA Drug Safety Update June 2016: Topical miconazole, including oral gel: reminder of potential for serious interactions with warfarin
- MHRA Drug Safety Update September 2017: Miconazole (Daktarin): over-the-counter oral gel contraindicated in patients taking warfarin
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people
- UKMI Q&A: Can miconazole oral gel be used by patients taking a statin?